MINNEAPOLIS--(BUSINESS WIRE)--Piper Jaffray (NYSE: PJC) is pleased to announce the addition of Dr. Charles Duncan as managing director and senior research analyst in its biotechnology research platform. He will be based in the firm’s New York office, focused specifically on small- and mid-cap emerging growth biotechnology companies.
“Piper Jaffray is highly committed to further advancing its market leading position in specialty areas of healthcare, including biotechnology. Charles adds experience to an already well-established platform, now with a total of four senior analysts and a significant coverage footprint across specialty pharmaceuticals and biotechnology sectors”
Duncan brings more than 17 years of sell-side experience, most recently serving as an analyst at JMP Securities since 2002, and previously at Dresdner Kleinwort Wasserstein, Vector Healthcare Group - Prudential Securities, Tucker Anthony Cleary Gull and Chatfield Dean & Co. Duncan has been recognized by industry sources, including the StarMine Analyst Awards, as being among the best analysts for his fundamental and timely analysis.
"Piper Jaffray is highly committed to further advancing its market leading position in specialty areas of healthcare, including biotechnology. Charles adds experience to an already well-established platform, now with a total of four senior analysts and a significant coverage footprint across specialty pharmaceuticals and biotechnology sectors,” commented Jeff Klinefelter, global head of equities for Piper Jaffray. “The firm will continue to focus efforts on providing growth companies with strategic alternatives for funding, while offering investors opportunities to participate in early-stage growth in exciting areas of drug discovery."
Duncan began his career as a manager of clinical development at Global Drug Development, Inc., a pharmaceutical development consulting firm where he also launched InfusionVision Medical, a venture-backed start-up medical device company. He is a graduate of the University of Wisconsin and holds a doctorate in neuropharmacology from the University of Colorado.
Piper Jaffray has a total of 30 senior research analysts located in Minneapolis, New York, San Francisco and Chicago. The firm provides coverage on 565 companies globally in key sectors: business and financial services; clean technology and renewables; consumer; healthcare; industrials; and technology, media and telecommunications.
About Piper Jaffray
Piper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Proven advisory teams combine deep industry, product and sector expertise with ready access to capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London and Zurich. www.piperjaffray.com
Since 1895. Member FINRA, NYSE and SIPC.
© 2012 Piper Jaffray & Co.